Qimin F. Zhan

Key Laboratory Of Carcinogenesis And Translational Research
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 222 publications

Corrigendum to "miR-503-3p promotes epithelial-mesenchymal transition in breast cancer by directly targeting SMAD2 and E-cadherin" [J. Genet. Genom. (2017) 44, 75-84].

Corrigendum to "miR-503-3p promotes epithelial-mesenchymal transition in breast cancer by directly targeting SMAD2 and E-cadherin" [J. Genet. Genom. (2017) 44, 75-84].

Journal: Journal of genetics and genomics = Yi chuan xue bao

Published: September 04, 2026

Correction: The chromosome 11q13.3 amplification associated lymph node metastasis is driven by miR-548k through modulating tumor microenvironment.

Correction: The chromosome 11q13.3 amplification associated lymph node metastasis is driven by miR-548k through modulating tumor microenvironment.

Journal: Molecular cancer

Published: February 08, 2026

Targeting DGKα/PA axis inhibits tumor immune evasion and augments sensitivity to immunotherapy in gastrointestinal cancers.

Targeting DGKα/PA axis inhibits tumor immune evasion and augments sensitivity to immunotherapy in gastrointestinal cancers.

Journal: iMeta

Published: February 03, 2026

Corrigendum to "PTBP1 promotes IRES-mediated translation of cyclin B1 in cancer".

Corrigendum to "PTBP1 promotes IRES-mediated translation of cyclin B1 in cancer".

Journal: Acta biochimica et biophysica Sinica

Published: December 24, 2025

Targeting focal adhesion kinase: from molecular mechanisms to next-generation cancer therapeutics.

Targeting focal adhesion kinase: from molecular mechanisms to next-generation cancer therapeutics.

Journal: Science bulletin

Published: December 12, 2025

A Retrospective Observational Study of Safety and Effectiveness of Abemaciclib in Chinese Patients with Breast Cancer.

A Retrospective Observational Study of Safety and Effectiveness of Abemaciclib in Chinese Patients with Breast Cancer.

Journal: Advances in therapy

Published: November 22, 2025

Strain-level genetic heterogeneity and colonization dynamics drive microbiome therapeutic efficacy.

Strain-level genetic heterogeneity and colonization dynamics drive microbiome therapeutic efficacy.

Journal: Cell host & microbe

Published: September 30, 2025

CAPZA1 Suppressed the Progression of Esophageal Squamous Cell Carcinoma by Binding to hnRNP K and PTPB1 to Influence Its mRNA Stability.

CAPZA1 Suppressed the Progression of Esophageal Squamous Cell Carcinoma by Binding to hnRNP K and PTPB1 to Influence Its mRNA Stability.

Journal: Cancer medicine

Published: September 09, 2025

Halofuginone is a Molecular Glue Degrader of Integrin β4.

Halofuginone is a Molecular Glue Degrader of Integrin β4.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: August 20, 2025

Geospatial genetic evolution and phenotypic plasticity in triple-negative breast cancer.

Geospatial genetic evolution and phenotypic plasticity in triple-negative breast cancer.

Journal: Genome medicine

Published: May 27, 2025

PAF signaling axis functions as biomarker or target for esophageal squamous cell carcinoma diagnosis or treatment.

PAF signaling axis functions as biomarker or target for esophageal squamous cell carcinoma diagnosis or treatment.

Journal: Cancer letters

Published: May 24, 2025

Single-cell integration analysis reveals molecular signatures of the tumor microenvironment in early-onset colorectal cancer.

Single-cell integration analysis reveals molecular signatures of the tumor microenvironment in early-onset colorectal cancer.

Journal: NPJ precision oncology

Published: May 05, 2025

Showing 1-12 of 222

Last Updated: 09/26/2026